We are live on ! Find out more
FSTX

F-star Therapeutics, Inc. Common Stock
FSTX

Delisted

FSTX was delisted on the 8th of March, 2023.

Back to rankings

57 hedge funds and large institutions have $73.5M invested in F-star Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

67% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 12

12% more funds holding

Funds holding: 51 → 57 (+6)

13% less capital invested

Capital invested by funds: $84.6M → $73.5M (-$11.2M)

Holders
57
Holders Change
+6
Holders Change %
+11.76%
% of All Funds
1.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
20
Reduced
12
Closed
3
Calls
$2.08M
Puts
–
Net Calls
+$2.08M
Net Calls Change
-$332K

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$2.81M
2
BlackRock
BlackRock
New York
+$801K
3
SFM
Sphera Funds Management
Israel
+$574K
4
HP
Hikari Power
Japan
+$474K
5
FI
Fosun International
China
+$350K

Top Sellers

Rank Fund Capital Flow
1
SI
Sofinnova Investments
California
-$2.29M
2
Jennison Associates
Jennison Associates
New York
-$1.71M
3
SCM
Stonepine Capital Management
Oregon
-$856K
4
SAM
Sectoral Asset Management
Quebec, Canada
-$450K
5
CWG
C WorldWide Group
Denmark
-$313K
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
26
California State Teachers Retirement System (CalSTRS)
California
$220K – – –
CC
27
Caxton Corporation
New Jersey
$219K +$540 +12 +0.2%
Wells Fargo
28
Wells Fargo
California
$208K +$108K +2,407 +92%
Dimensional Fund Advisors
29
Dimensional Fund Advisors
Texas
$206K +$223K +4,967 New
LF
30
Lee Financial
Texas
$195K – – –
PAM
31
Pegasus Asset Management
New York
$195K +$211K +4,688 New
Deutsche Bank
32
Deutsche Bank
Germany
$187K -$161K -3,583 -44%
RhumbLine Advisers
33
RhumbLine Advisers
Massachusetts
$174K +$74.5K +1,656 +65%
TCIM
34
TIAA CREF Investment Management
New York
$161K -$7.11K -158 -4%
State of Wisconsin Investment Board
35
State of Wisconsin Investment Board
Wisconsin
$151K +$163K +3,625 New
TA
36
Teachers Advisors
New York
$149K +$9.08K +202 +6%
JP Morgan Chase
37
JP Morgan Chase
New York
$146K +$15.1K +336 +11%
William Blair & Company
38
William Blair & Company
Illinois
$132K +$27.6K +613 +24%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$128K – – –
BFM
40
Boothbay Fund Management
New York
$112K +$121K +2,685 New
AIG
41
American International Group
New York
$95K -$2.07K -46 -2%
UBS Group
42
UBS Group
Switzerland
$84K +$14.2K +315 +19%
Bank of America
43
Bank of America
North Carolina
$79K +$53.2K +1,184 +168%
Citigroup
44
Citigroup
New York
$41K +$899 +20 +2%
SO
45
STRS Ohio
Ohio
$33K – – –
MAM
46
Meeder Asset Management
Ohio
$27K +$3.87K +86 +15%
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$24K -$2.88K -64 -10%
Legal & General Group
48
Legal & General Group
United Kingdom
$24K – – –
AIP
49
Ameritas Investment Partners
Nebraska
$11K – – –
LTFS
50
Ladenburg Thalmann Financial Services
Florida
$6K – – –
1
2
3

FSTX Hedge Fund Activity: Q4 2018 in Review

57 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in F-star Therapeutics, Inc. Common Stock (FSTX) for Q4 2018, worth a combined $73.5M — down 13% from $84.6M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new FSTX positions and 3 closed out — a net gain of 6 holders — while 20 added to existing stakes and 12 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $2.81M. The largest seller was Sofinnova Investments, exiting entirely with an estimated $2.29M sold.

  • 57 institutional investors held F-star Therapeutics, Inc. Common Stock (FSTX) as of Q4 2018, up from 51 in Q3 2018.
  • Funds reported $73.5M of F-star Therapeutics, Inc. Common Stock stock for Q4 2018, down 13% quarter-over-quarter.
  • 9 funds opened new F-star Therapeutics, Inc. Common Stock positions in Q4 2018 and 3 closed out, a net change of +6 holders.
  • The largest F-star Therapeutics, Inc. Common Stock buyer in Q4 2018 was Adage Capital Partners, an estimated $2.81M added.
  • The largest F-star Therapeutics, Inc. Common Stock seller in Q4 2018 was Sofinnova Investments, an estimated $2.29M sold.

Based on aggregated 13F filings for Q4 2018.